NVNO

Envveno Medical Corporation

• Seeking Alpha·03/27 12:55

  enVVeno Medical GAAP EPS of -$33.06

• Benzinga·03/27 12:43

  enVVeno Medical Q4 EPS $(6.05) Misses $(0.30) Estimate

• TipRanks·03/27 12:40

  enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year

• TipRanks·03/27 12:39

  enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2026

• Reuters·03/26 20:25

  enVVeno Medical FY2025 net loss narrows 11% to $20 million; revenue logs no revenue

• Reuters·03/13 20:06

  enVVeno Medical Director Francis Duhay Disposes of Common Shares

• Benzinga·02/20 17:05

  12 Health Care Stocks Moving In Friday's Intraday Session

• Reuters·02/20 14:51

  BRAEDEN LICHTI- NORTHSTRIVE'S FUND RECOMMENDATIONS TO ENVVENOS BOARD TO LAUNCH FORMAL STRATEGIC REVIEW TO EITHER RETURN CAPITAL OR PURSUE MERGER

• Reuters·02/20 14:51

  BRAEDEN LICHTI- REPORTS 5.05% STAKE IN ENVVENO MEDICAL CORP AS OF FEB 20 - SEC FILING

• Reuters·02/20 14:51

  BRAEDEN LICHTI- NORTHSTRIVE'S FUND RECOMMENDATIONS TO ENVVENO MEDICAL'S BOARD TO IMMEDIATELY HALT ALL CLINICAL OPERATIONS

• Reuters·02/20 14:51

  BRAEDEN LICHTI- NORTHSTRIVE FUND HAS REQUESTED TO MEET WITH SENIOR MANAGEMENT OF ENVVENO MEDICAL IN BOARD LETTER

• TipRanks·02/04 14:00

  enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans

• TipRanks·02/04 13:46

  enVVeno Medical regains compliance with Nasdaq minimum bid price rule

• Benzinga·02/04 13:34

  enVVeno Medical Corporation Announces Nasdaq Compliance Regained With Minimum $1.00 Closing Bid Price For 10 Days

• Benzinga·02/02 12:05

  12 Health Care Stocks Moving In Monday's Pre-Market Session